Butler M, McKay RA, Popoff IJ, Gaarde WA, Witchell D, Murray SF, Dean NM, Bhanot S, Monia BP: Specific inhibition of PTEN expression reverses hyperglycemia in diabetic mice. Diabetes 51:1028–1034, 2002

Table 1, as referenced on page 1031, was not shown in the above-listed article and is subsequently given here.

TABLE 1

Effects of PTEN AS1 on serum triglyceride and cholesterol concentrations, and body weights in db/db mice after 28 days of treatment (n = 5–6)

db/db mice
+/−
SalineASI 25 mg/kgASI 50 mg/kgUC 50 mg/kgSaline
Triglycerides (mg/dl) 205 ± 33 120 ± 14* 98 ± 36† 182 ± 36 101 ± 8 
Cholesterol (mg/dl) 130 ± 5 110 ± 5† 96 ± 5† 126 ± 5 89 ± 2 
Body weight increase (g) 2.7 ± 0.4 6.7 ± 0.2† 8.7 ± 0.6† 2.6 ± 1.1 1.2 ± 0.8 
db/db mice
+/−
SalineASI 25 mg/kgASI 50 mg/kgUC 50 mg/kgSaline
Triglycerides (mg/dl) 205 ± 33 120 ± 14* 98 ± 36† 182 ± 36 101 ± 8 
Cholesterol (mg/dl) 130 ± 5 110 ± 5† 96 ± 5† 126 ± 5 89 ± 2 
Body weight increase (g) 2.7 ± 0.4 6.7 ± 0.2† 8.7 ± 0.6† 2.6 ± 1.1 1.2 ± 0.8 

Data are means ± SE. Statistical analysis was performed using ANOVA followed by Bonferroni-Dunn.

*

P < 0.05 and

†

P < 0.005 vs. saline-treated db/db mice.

View Large
View Original Article
DIABETES
2002